G:NYSEGenpact Limited Analysis

Genpact’s stock is currently trading well beneath its long‑term moving averages, with the 20‑day, 50‑day and 200‑day SMAs all sitting above the market price, confirming a bearish price direction. The RSI sits in the mid‑range, indicating no immediate over‑bought condition, while the MACD line has just crossed above its signal, producing a small positive histogram that hints at an nascent bullish momentum. A beta well under one suggests the share moves less than the broader market, yet a 30‑day volatility above 25% points to sizable price swings. The forward P/E is comfortably lower than the industry average, and the dividend yield, though modest, is backed by a payout ratio under 25%, supporting sustainability. Recent earnings fell short of expectations, tempering short‑term sentiment despite a broader “extreme greed” market tone.
Fundamentally, the company enjoys solid cash generation, a healthy free‑cash‑flow conversion and a debt‑to‑equity ratio that, while elevated, is manageable given its cash reserves. The DCF model implies a fair value more than double the current price, translating to a near‑30% upside, and analysts’ consensus remains a “buy” with a median target around $49. Growth drivers such as rising demand for BPO, AI‑enabled automation and digital transformation services underpin a stable revenue expansion outlook. The modest dividend, low payout and strong ROE further enhance the appeal for income‑oriented investors. Taken together, the valuation gap and secular tailwinds outweigh the near‑term technical weakness, making Genpact a compelling candidate for medium‑ to long‑term accumulation.